OncoGenex Announces that the Rainierâ¢ Clinical Trial Evaluating Apatorsen (OGX-427) in Combination with ABRAXANEÂ® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer is Now Open for Enrollment